Oncology

Lindsay Hallman, CVT, CCMT, VTS (Oncology), and Katelyn McDonald, CVT, VTS (Oncology), discuss what oncology patients may experience in a dvm360 interview.

OS Therapeutics' veterinary division is developing OST-HER2 for canine osteosarcoma treatment.

Zachary Wright, DVM, DACVIM (Oncology), highlights the unique clinical presentations of mast cell disease in cats compared with dogs.

Lindsay Hallman, CVT, CCMT, VTS (Oncology) and Katelyn McDonald, CVT, VTS (Oncology), discuss methods for a calm administration and positive pet experience.

In a session at the New York Vet Show, Ann E. Hohenhaus, DVM, DACVIM (Oncology, SAIM), offered a comprehensive list of resources useful to veterinarians with oncology patients.

Explore common oncology mistakes in veterinary practice with Rachel Venable, DVM, MS, DACVIM (Oncology) on this episode of The Vet Blast Podcast presented by dvm360.

Akston Biosciences Corporation partnered with Purdue University to develop a drug targeting PD-L1 in dogs with solid tumors.

VolitionRx Limited donated its Nu.Q Vet Cancer Test to support dogs that provide emotional support and comfort to those impacted by crises and disasters.

Female dogs are at a higher risk of developing breast cancer than women.

Discover how early cancer detection through the Cancer DX test enhances canine patient outcomes in this episode of The Vet Blast Podcast presented by dvm360.

The survey also found that as the number of lumps seen increased, the likelihood of sampling decreased. Could a “wait-and-see” approach be costing dogs valuable treatment time and compromising outcomes?

The treatment’s success could have important implications for human cancer research.

The pioneering research was launched by the Humanimal Trust, a United Kingdom charity.

Learn more about cancer screening tests, including some of the latest ones, and more in this interview with Zachary Wright, DVM, DACVIM (Oncology).

From supporting identification of certain cell characteristics to complementing clinical expertise with remote pathologist review, Vetscan Imagyst® AI Masses is designed to assist with challenging cases – giving teams added confidence at the point of care. In this video, Zoetis leaders highlight what these advances mean for the clinic, the pet owner, and the patient.

Cornell University Hospital for Animals has installed Varian's Edge linear accelerator and a Siemens Naeotom Alpha photon-counting CT scanner to improve outcomes

A new pilot clinical study will explore the safety and effectiveness of 2 anti-canine monoclonal antibodies on solid tumors in dogs.

The funds will be used to support pet owners who cannot afford chemotherapy, surgery and other lifesaving treatment.

One of the biggest challenges is knowing when and where to refer a client.

Jeffrey N. Bryan, DVM, PhD, MS, DACVIM, discusses current methods and the need for advancement in how bone cancer is managed in dogs.

ELIAS Cancer Immunotherapy was combined with chemotherapy in a study with results presented at the 2025 ACVIM Forum.

Frederick R. Appelbaum, MD, recognized for advancing marrow transplantation, talks about the impact of canine research on human and veterinary medicine.

Renowned American physician‑scientist Frederick R. Appelbaum, MD, discusses the development of bone marrow transplantation as a curative therapy at the 2025 ACVIM Forum.